Leaving UL Solutions website
Within UL Solutions we provide a broad portfolio of offerings to all the medical device industries. This includes certification, Approved/Notified Body and consultancy services. In order to protect and prevent any conflict of interest, perception of conflict of interest and protection of both our brand and our customers brand, we have processes in place to identify and manage any potential conflicts of interest and maintain impartiality. UL Solutions is unable to provide consultancy services to EU MDD, MDR or IVDD Notified Body, UKCA MD Approved Body or MDSAP Customers.
  • Regulatory Update

Brazil’s Cosmetic Ingredient Regulations Updated

On June 11, 2026, Brazil’s cosmetic framework was updated with changes to prohibited and restricted substance lists, as well as the addition of new labeling requirements and compliance deadlines.

Contact us
cosmetics

October 9, 2026

By Raissa Havens, Senior Regulatory Specialist

On June 11, 2026, two resolutions on cosmetic ingredients were updated as part of ANVISA's broader modernization of the Brazilian cosmetics ingredient framework and bringing Brazil into alignment with the latest MERCOSUR cosmetics requirements.

Resolution RDC 529/2021 was amended through RDC 1.030 of June 11, 2026, incorporating MERCOSUR Resolution GMC No. 07/25 with inclusions, deletions and changes to the list of prohibited substances.

Thirteen new entries were added to the prohibited list, although some entries cover groups which contain multiple individual substances or CAS numbers. Substances were also deleted from the prohibited list and placed in the restricted-substances framework, where use is allowed only under applicable conditions, including:

  • Benzoyl peroxide, CAS 94-36-0
  • Methyleugenol, CAS 93-15-2
  • Hydroquinone, CAS 123-31-9
  • Azelaic acid, CAS 123-99-9

Resolution RDC 530/2021 was revoked by RDC 1.029 of June 11, 2026. RDC 1.029/2026 updates the maximum permitted concentrations, usage limitations, and mandatory labeling warnings for a wide range of restricted substances.

Both resolutions were published in the Federal Official Gazette on June 15, 2026, and entered into force on the date of publication.

For Resolution RDC 1.030/2026, there is a 12-month transition period for companies to comply, ending on June 15, 2027, except for substances BUTYLPHENYL METHYLPROPIONAL and HYDROXYISOHEXYL 3-CYCLOHEXENE CARBOXALDEHYDE, which have an 18-month transition from publication date for compliance.

For Resolution RDC 1.029/2026, there is a 24-month transition period for companies to comply, which ends on June 15, 2028.

The ChemADVISOR® Regulatory Database will reflect these updates.

Reference

Resolution RDC 1.029 of June 11, 2026 Resolution RDC 1.030 of June 11, 2026

Related services
Photo of a person signing a contract
  • Service

Chemical Regulatory Compliance
Smiling man sitting at a desk in front of a computer monitor
  • Training

Chemical Compliance Training
Illustrative SDS pictogram with fire icon
  • Software

SDS Authoring Software
X

Get connected with our sales team

Thanks for your interest in our products and services. Let's collect some information so we can connect you with the right person.